Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
10/2005
10/06/2005WO2005093071A1 Artificial actinomyces h+-pyrophosphatase gene and system for expressing the same in escherichia coli
10/06/2005WO2005093068A1 Novel protein and promoter
10/06/2005WO2005093066A1 Marker gene for arthrorheumatism test
10/06/2005WO2005093064A1 Novel galectin 9 modification protein and use thereof
10/06/2005WO2005093061A1 METHOD OF ANALYZING PANCREATIC β-CELL AMOUNT AND/OR PANCREATIC β-CELL FUNCTION AND UTILIZATION THEREOF
10/06/2005WO2005093060A1 Process for producing 1,3-propanediol and/or 3-hydroxypropionic acid
10/06/2005WO2005093055A1 Transformed yeasts for detecting and measuring dioxins and methods for detecting, measuring and screening for dioxins employing the same
10/06/2005WO2005093045A2 Cell concentration and pathogen recovery
10/06/2005WO2005093043A1 Dna immunocontraceptive vaccines and uses thereof
10/06/2005WO2005093042A1 Novel thermophilic bacterium and soil blend containing the same
10/06/2005WO2005093041A1 Mutated xylose reductase in xylose-fermentation by s. cerevisiae
10/06/2005WO2005093040A1 Eukaryotic cells expressing phycocyanin
10/06/2005WO2005092916A1 Novel fermentation products
10/06/2005WO2005092069A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
10/06/2005WO2005091733A2 Traits in recombinant xylose-growing saccharomyces cerevisiae strains using genome-wide transcription analysis
10/06/2005WO2005023850A3 Method for producing inosine and 5'-inosinic acid by fermentation using bacterium belonging to the genus escherichia
10/06/2005WO2004093787A3 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms
10/06/2005WO2004032877A3 Compositions, organisms and methodologies employing a novel human kinase
10/06/2005US20050222248 3'-hydroxy-dihydrodaidzein, 5-hydroxy-O-demethylangolesin; for treating hormone dependent conditions and other diseases and disorders; anticarcinogenic agents; menopausal syndrome; osteoporosis; rheumatic diseases; atherosclerosis; premenstrual syndrome; coronary artery spasm; vascular diseases
10/06/2005US20050222062 Decoy for treating and/or preventing th2 cytokine-associated allergic disease, gata3 mutant protein and medicinal compositions containing the same
10/06/2005US20050222057 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo
10/06/2005US20050221474 Gene promoters
10/06/2005US20050221466 Alanine 2,3,aminomutase
10/06/2005US20050221465 for culturing a microorganism in a growth medium prepared from a sterile nutrient composition derived from the biomass of a culture of bacteria including methanotrophic bacteria; suitable for use as growth substrates for heterotrophic microorganisms
10/06/2005US20050221461 Genetic engineered Dna; textile cleaning compounds
10/06/2005US20050221460 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton
10/06/2005US20050221455 Production of monatin and monatin precursors
10/06/2005US20050221453 L-cysteine producing microorganism and method for producing L-cysteine
10/06/2005US20050221452 Feedback-resistant pyruvate carboxylase gene from corynebacterium
10/06/2005US20050221448 Using transgenic gramnegative bacteria comprising isocitrate dehydrogenase kinase/phosphatase (ACEK) gene sequences as bioreactor for fermentation of threonine for use in medicines, cosmetics and animal feeds
10/06/2005US20050221447 Mannosyl transfer with regeneration of GDP-mannose
10/06/2005US20050221446 Methods for producing hyaluronic acid in a Bacillus cell
10/06/2005US20050221445 Useful as agents that inhibit virus infection of cells
10/06/2005US20050221442 Bacterial host cell for the direct expression of peptides
10/06/2005US20050221440 Nucleic acid containing a reading frame with a first sequence encoding segments of the tumor associated antigen, PRAME (preferentially expressed antigen in melanoma); immunogenic; cluster sequences have affinity for a same Major Histocompatibility Complex receptor peptide binding cleft
10/06/2005US20050221439 Genes of an otitis media isolate of haemophilus influenzae
10/06/2005US20050221434 Receptor of the EDb-fibronectin domains
10/06/2005US20050221431 Conjugate having a polypeptide targeting moiety including a sequence of human vascular endothelial growth factor, human annexin V, fragment of anthrax lethal factor, or single chain vascular endothelial growth factor covalently bonded via a disulfide bone to a binding moiety such as an adapter protein
10/06/2005US20050221425 promoter is induced by a reduction in temperature; can be used for regulated expression of proteins, both homologous and heterologous, very efficiently and economically
10/06/2005US20050221423 Bacillus host cell
10/06/2005US20050221422 Novel galactose transferases, peptides thereof and nucleic acid encoding the same
10/06/2005US20050221420 Nogo receptor homologues and their use
10/06/2005US20050221394 Ion channel
10/06/2005US20050221370 Systems and methods for ordering, performing, and reporting genetic screening
10/06/2005US20050221369 BGL3 beta-glucosidase and nucleic acids encoding the same
10/06/2005US20050221346 May be used to detect the presence of a cancer or to evaluate the prognosis of a known disease
10/06/2005US20050221344 Interferon-Like molecules and uses thereof
10/06/2005US20050221330 Glial cell line-derived neurotrophic factor (GDNF); nervous system disorders, autonomic nervous system, shingles, asthma, irritable bowel, inflammatory bowel, constipation, headache, arthritis, spinal cord injury, chronic back pain, hypertension, mucositis, diabetes, fibromyalgia, and wound healing
10/06/2005US20050221325 Detection of secreted polypeptides
10/06/2005US20050221303 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/06/2005US20050220958 Pasteurisation process for microbial cells and microbial oil
10/06/2005US20050220948 Denatured spirulina and manufacturing method thereof
10/06/2005US20050220811 Identification of virulence associated regions rd1 and rd5 leading to improve vaccine of m. bovis bcg and m. microti
10/06/2005US20050220809 Nucleotide sequence coding for a tolc and a defined amino acid sequence
10/06/2005US20050220808 approximately 20-25 amino acids in length which are portions of the N termini of the M proteins of the most prevalent United States Group A Streptococcus serotypes; do not elicit tissue cross-reactive antibodies
10/06/2005US20050220807 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/06/2005US20050220805 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines
10/06/2005US20050220790 Amino-terminally truncated rantes as chemokine antagonists
10/06/2005US20050220777 Selection of lactic acid bacteria enhancing the immune response against Streptococcus pneumoniae
10/06/2005US20050220776 Lactobacillus strains
10/06/2005US20050220769 Novel endophytic fungi and methods of use
10/06/2005US20050220757 Chemokine mutants acting as chemokine antagonists
10/06/2005DE102004013503A1 Verfahren zur Herstellung von L-Aminosäuren unter Verwendung coryneformer Bakterien A process for the preparation of L-amino acids using coryneform bacteria
10/06/2005CA2563886A1 Compositions and methods for controlling insects related to the octopamine receptor
10/06/2005CA2561696A1 Novel modified galectin 9 proteins and use thereof
10/06/2005CA2561502A1 Marker gene for arthrorheumatism test
10/06/2005CA2561302A1 Mutated xylose reductase in xylose-fermentation by s. cerevisiae
10/06/2005CA2560894A1 Traits in recombinant xylose-growing saccharomyces cerevisiae strains using genome-wide transcription analysis
10/06/2005CA2560590A1 Modified xylanases exhibiting improved expression
10/06/2005CA2559943A1 Cell concentration and pathogen recovery
10/05/2005EP1582584A1 PROCESS FOR PRODUCING PNPase
10/05/2005EP1582529A1 Mutant tyrosine repressor, a gene encoding the same, and a method for producing L-DOPA
10/05/2005EP1581644A1 Purification of polypeptides
10/05/2005EP1581638A1 P153 and p156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof
10/05/2005EP1581632A2 Mutations affecting carotenoid production
10/05/2005EP1581628A2 A set of ubiquitous cellular proteins involved in viral life cycle
10/05/2005EP1581626A2 Culturing anaplasma
10/05/2005EP1581624A2 Eukaryotic genes involved in adult lifespan regulation
10/05/2005EP1581619A2 Polyhydroxyalkanoate production by coenzyme a-dependent aldehyde dehydrogenase pathways
10/05/2005EP1581618A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/05/2005EP1581616A2 Novel proteins and nucleic acids encoding same
10/05/2005EP1581614A2 Nucleotide sequences for gene regulation and methods of use thereof
10/05/2005EP1581552A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
10/05/2005EP1581119A2 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
10/05/2005EP1581092A2 Compounds and methods for treatment and diagnosis of chlamydial infection
10/05/2005EP1581064A1 Controlled release encapsulated bioactive substances
10/05/2005EP1581054A2 Treatment of hsv-related patholgies using ssdna
10/05/2005EP1395662B1 Process for the preparation of d-pantothenic acid and/or salts thereof
10/05/2005EP1395661B1 Process for the preparation of d-pantothenic acid and/or salts thereof
10/05/2005EP1123389B1 A method of affinity separation and ligands for use therein
10/05/2005EP1034278B1 Method for the production of glycerol by recombinant organisms
10/05/2005EP0970183B1 Micropathological patient replica based on unadulterated whole blood
10/05/2005CN1678757A Compositions and methods for determining the replication capacity of a pathogenic virus
10/05/2005CN1678742A Novel aldolase and production process of substituted alpha-keto acids
10/05/2005CN1678736A Thermostable ribonuclease H
10/05/2005CN1678735A Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor
10/05/2005CN1678633A Anti-IGF-I receptor antibody
10/05/2005CN1678630A HCV fusion proteins with modified NS3 domains
10/05/2005CN1678628A Stress proteins and peptides and methods of use thereof
10/05/2005CN1678625A Humanized anti-lymphotoyin beta receptor antibodies
1 ... 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 ... 1489